THE GH, IGF-1, AND INSULIN INTERPLAY IN TYPE 1 DIABETES MELLITUS THE GH, IGF-1, AND INSULIN INTERPLAY IN TYPE 2 DIABETES MELLITUS AND OBESITY THE GH, IGF-1, AND INSULIN INTERPLAY IN LIVER FAILURE THE GH, IGF-1, AND INSULIN INTERPLAY IN ACROMEGALY CONCLUSIONS Article information References ABSTRACT This review intends to provide the reader with a practical overview of several (patho)physiological conditions in which knowledge of the interplay between growth hormone (GH), insulin-like growth factor-1 (IGF-1), and insulin is important
For Korner, whats particularly worrying when it comes to microdosing is the lack of research, given that these medications carry proven cardiovascular and kidney benefits that have never been evaluated at microdose levels
Expression of glutathione S -transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy
Gill et al., 2021)
Choose one GH pathway + local peptides for best results
At the studys conclusion, researchers found that participants who took GLP-1 medications containing semaglutide or tirzepatide had a 41% decrease in their overall risk of developing an obesity-related cancer
